Literature DB >> 26687684

Management of rheumatoid arthritis: what happens and what does not happen in real life.

Daniel Aletaha1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26687684     DOI: 10.1007/s00296-015-3402-2

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


× No keyword cloud information.
  7 in total

1.  Persistence of subclinical sonographic joint activity in rheumatoid arthritis in sustained clinical remission.

Authors:  M Gärtner; F Alasti; G Supp; P Mandl; J S Smolen; D Aletaha
Journal:  Ann Rheum Dis       Date:  2015-05-14       Impact factor: 19.103

2.  Discrepancies between patients and physicians in their perceptions of rheumatoid arthritis disease activity.

Authors:  Paul Studenic; Helga Radner; Josef S Smolen; Daniel Aletaha
Journal:  Arthritis Rheum       Date:  2012-09

3.  American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials.

Authors:  David T Felson; Josef S Smolen; George Wells; Bin Zhang; Lilian H D van Tuyl; Julia Funovits; Daniel Aletaha; Cornelia F Allaart; Joan Bathon; Stefano Bombardieri; Peter Brooks; Andrew Brown; Marco Matucci-Cerinic; Hyon Choi; Bernard Combe; Maarten de Wit; Maxime Dougados; Paul Emery; Daniel Furst; Juan Gomez-Reino; Gillian Hawker; Edward Keystone; Dinesh Khanna; John Kirwan; Tore K Kvien; Robert Landewé; Joachim Listing; Kaleb Michaud; Emilio Martin-Mola; Pamela Montie; Theodore Pincus; Pamela Richards; Jeffrey N Siegel; Lee S Simon; Tuulikki Sokka; Vibeke Strand; Peter Tugwell; Alan Tyndall; Desirée van der Heijde; Suzan Verstappen; Barbara White; Frederick Wolfe; Angela Zink; Maarten Boers
Journal:  Ann Rheum Dis       Date:  2011-03       Impact factor: 19.103

Review 4.  Remission of rheumatoid arthritis: should we care about definitions?

Authors:  D Aletaha; J S Smolen
Journal:  Clin Exp Rheumatol       Date:  2006 Nov-Dec       Impact factor: 4.473

5.  Factors associated with the intensification of treatment in rheumatoid arthritis in clinical practice.

Authors:  Antonio Naranjo; Laura Cáceres; José Ángel Hernández-Beriaín; Félix Francisco; Soledad Ojeda; Sigrid Talaverano; Javier Nóvoa-Medina; José Adán Martín; Esmeralda Delgado; Elisa Trujillo; Fátima Álvarez; Laura Magdalena; Carlos Rodríguez-Lozano
Journal:  Rheumatol Int       Date:  2015-08-04       Impact factor: 2.631

6.  Treating rheumatoid arthritis to target: recommendations of an international task force.

Authors:  Josef S Smolen; Daniel Aletaha; Johannes W J Bijlsma; Ferdinand C Breedveld; Dimitrios Boumpas; Gerd Burmester; Bernard Combe; Maurizio Cutolo; Maarten de Wit; Maxime Dougados; Paul Emery; Alan Gibofsky; Juan Jesus Gomez-Reino; Boulos Haraoui; Joachim Kalden; Edward C Keystone; Tore K Kvien; Iain McInnes; Emilio Martin-Mola; Carlomaurizio Montecucco; Monika Schoels; Désirée van der Heijde; Desirée van der Heijde
Journal:  Ann Rheum Dis       Date:  2010-03-09       Impact factor: 19.103

7.  Tightening up? Impact of musculoskeletal ultrasound disease activity assessment on early rheumatoid arthritis patients treated using a treat to target strategy.

Authors:  James Dale; David Purves; Alex McConnachie; Iain McInnes; Duncan Porter
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-01       Impact factor: 4.794

  7 in total
  1 in total

1.  Radiographic changes in TMJ in relation to serology and disease activity in RA patients.

Authors:  Mostafa Mahmoud Youssef Mohamed; Mushira M Dahaba; Mary Medhat Farid; Adel Mahmoud Ali Elsayed
Journal:  Dentomaxillofac Radiol       Date:  2019-09-20       Impact factor: 2.419

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.